Premium
BridgeBio Pharma Inc (BBIO)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Derma... BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy. The company focus on genetic diseases because they exist at the intersection of high unmet patient need and tractable biology. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -3.69 | -9.72588297312 | 37.94 | 38.05 | 32.88 | 4774446 | 34.39679345 | CS |
| 4 | -1.58 | -4.4097125314 | 35.83 | 39.38 | 30.78 | 3423575 | 34.12523803 | CS |
| 12 | 7.69 | 28.953313253 | 26.56 | 39.38 | 25.34 | 2751687 | 32.80756092 | CS |
| 26 | 9.28 | 37.164597517 | 24.97 | 39.38 | 21.72 | 2484622 | 29.37112226 | CS |
| 52 | -0.88 | -2.5049814973 | 35.13 | 39.38 | 21.62 | 2107626 | 28.41970601 | CS |
| 156 | 26.36 | 334.093789607 | 7.89 | 44.32 | 4.98 | 2143716 | 21.47575991 | CS |
| 260 | 4.84 | 16.4569874192 | 29.41 | 73.5 | 4.98 | 1776848 | 24.85209988 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
